RMIT University is pleased to offer students interested in new gold-based compounds as alternatives to current ovarian cancer chemotherapies the PhD Scholarships in Gold-Based Drugs for the Effective Treatment of Ovarian Cancer in Australia for the academic year 2022-2023.
All international and domestic national students can apply for this funding scheme. The scholarship will support a 3-year PhD candidature working in the Cancer, Ageing & Vaccine Laboratory. Applicants must reside in Australia to take this full RMIT Scholarship.
- Award
- Application Process
- Clarity of Information
Summary
A perfect chance for students who want to study for a PhD degree with some financial support in Australia.RMIT University, one of Australia’s tertiary institutions, 15th highest-ranked university in Australia, and 250th in the world with a 5-Star QS ranking for excellence in higher education, is a higher education institute dedicated to helping shape a new urban and industrial renaissance in the global economy.
Why choose RMIT University? RMIT University is highly appreciated for its excellence in Education, Research, and Engagement with Industry and Community. RMIT aims to inspire and engage the audience to discover new ideas and perspectives by exploring cultural spaces and resources. It is among some of the most technologically advanced facilities in the world.